$IMV Presents Updated Data From Phase 1b2 Combo Clinical Trial in Advanced Ovarian Cancer at ESMOImmuno18 httpsglobenewswire.comnewsrelease2018121316663990enIMVIncPresentsUpdatedPositiveDataFromPhase1b2CombinationClinicalTrialin

$IMV Presents Updated Data From Phase 1b/2 Combo Clinical Trial in Advanced Ovarian Cancer at #ESMOImmuno18 https://globenewswire.com/news-release/2018/12/13/1666399/0/en/IMV-Inc-Presents-Updated-Positive-Data-From-Phase-1b-2-Combination-Clinical-Trial-in

06:01 EST 13 Dec 2018 | Odi Bruckman

More From BioPortfolio on "$IMV Presents Updated Data From Phase 1b/2 Combo Clinical Trial in Advanced Ovarian Cancer at #ESMOImmuno18 https://globenewswire.com/news-release/2018/12/13/1666399/0/en/IMV-Inc-Presents-Updated-Positive-Data-From-Phase-1b-2-Combination-Clinical-Trial-in"